Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.800
0.00 (0.00%)
Dec 4, 2025, 9:30 AM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $328.75 million as of December 5, 2025. Its market cap has decreased by -0.10% in one year.
Market Cap
328.75M
Enterprise Value
226.74M
Revenue
25.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.80
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 328.75M, a decrease of -38.94%. That is a compound annual growth rate of -8.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 328.75M | 1.20% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.91M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 363.73M |
| Nika Pharmaceuticals | 259.91M |
| HST Global | 131.71M |